Assessment of aortic valve disease by CT imaging
Not Applicable
- Registration Number
- CTRI/2010/091/000439
- Lead Sponsor
- JB Chemicals Pvt Ltd., 4th Floor, B-wing, Neelam Centre, behind cycle road, worli, Mumbai 400030
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
adults (>14years of age) with known or suspected aortic valvular dis aortic valvular disease due to either atherosclerotic, congenital or infective pathology
Exclusion Criteria
pediatric age group of 0 to 14years
Known allergy to contrast media, high sr. creatine levels, patients with significantly poor cardiac function in whom ECG gating with beta-blockers or SA node inhibitors is not advisable.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method obtaining aortic valve area by MDCTTimepoint: after CT imaging of the enitre study group comparison with 2D echo will be done.
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil